FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Coltman

Research Profile

Disorders

Prostatic Neoplasms

Chemicals & Drugs

Concepts & Ideas

Procedures

Geographic Areas

United States

Anatomy

Prostate

Co-author Network

Publications

TOP 3
M Scott Lucia; Amy K Darke; Phyllis J Goodman; Francisco G La Rosa; Howard L Parnes; Leslie G Ford; Charles A Coltman; Ian M Thompson
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
Ian M Thompson; Catherine M Tangen; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis Goodman; Howard L Parnes; Charles A Coltman
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy.
Ian M Thompson; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Charles A Coltman
Does the level of prostate cancer risk affect cancer prevention with finasteride?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Coltman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: M Scott Lucia; Amy K Darke; Phyllis J Goodman; Francisco G La Rosa; Howard L Parnes; Leslie G Ford; Charles A Coltman; Ian M Thompson
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.
Cancer prevention research (Philadelphia, Pa.) 2008;1(3):167-73.
2008: Ian M Thompson; Catherine M Tangen; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis Goodman; Howard L Parnes; Charles A Coltman
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy.
The Journal of urology 2008;180(2):544-7.
2008: Ian M Thompson; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Charles A Coltman
Does the level of prostate cancer risk affect cancer prevention with finasteride?
Urology 2008;71(5):854-7.
2007: M Scott Lucia; Jonathan I Epstein; Phyllis J Goodman; Amy K Darke; Victor E Reuter; Francisco Civantos; Catherine M Tangen; Howard L Parnes; Scott M Lippman; Francisco G La Rosa; Michael W Kattan; E David Crawford; Leslie G Ford; Charles A Coltman; Ian M Thompson
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(18):1375-83.
2007: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3076-81.
2007: Carol M Moinpour; Amy K Darke; Gary W Donaldson; Ian M Thompson; Connie Langley; Donna Pauler Ankerst; Donald L Patrick; John Ware; Patricia Anne Ganz; Sally A Shumaker; Scott M Lippman; Charles A Coltman
Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(13):1025-35.
2007: Ian M Thompson; M Scott Lucia; Mary W Redman; Amy K Darke; Francisco G La Rosa; Howard L Parnes; Scott M Lippman; Charles A Coltman
Finasteride decreases the risk of prostatic intraepithelial neoplasia.
The Journal of urology 2007;178(1):107-9; discussion 110.
2007: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; M Scott Lucia; Howard L Parnes; Scott M Lippman; Charles A Coltman
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.
The Journal of urology 2007;177(5):1749-52.
2006: Ian M Thompson; Chen Chi; Donna Pauler Ankerst; Phyllis J Goodman; Catherine M Tangen; Scott M Lippman; M Scott Lucia; Howard L Parnes; Charles A Coltman
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.
Journal of the National Cancer Institute 2006;98(16):1128-33.
2006: Phyllis J Goodman; Ian M Thompson; Catherine M Tangen; John J Crowley; Leslie G Ford; Charles A Coltman
The prostate cancer prevention trial: design, biases and interpretation of study results.
The Journal of urology 2006;175(6):2234-42.
2006: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2006;98(8):529-34.
2006: Joseph M Unger; Charles A Coltman; John J Crowley; Laura F Hutchins; Silvana Martino; Robert B Livingston; John S Macdonald; Charles D Blanke; David R Gandara; E David Crawford; Kathy S Albain
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):141-4.
2005: Ian M Thompson; Catherine M Tangen; Phyllis J Goodman; Jeffrey L Probstfield; Carol M Moinpour; Charles A Coltman
Erectile dysfunction and subsequent cardiovascular disease.
JAMA : the journal of the American Medical Association 2005;294(23):2996-3002.
2005: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
JAMA : the journal of the American Medical Association 2005;294(1):66-70.
2005: Joseph M Unger; Ian M Thompson; Michael LeBlanc; John J Crowley; Phyllis J Goodman; Leslie G Ford; Charles A Coltman
Estimated impact of the Prostate Cancer Prevention Trial on population mortality.
Cancer 2005;103(7):1375-80.
2005: Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Journal of the National Cancer Institute 2005;97(2):94-102.
2004: Joseph M Unger; Michael LeBlanc; Ian M Thompson; Charles A Coltman
The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies.
Urologic oncology 2004;22(4):362-8.
2004: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.
The New England journal of medicine 2004;350(22):2239-46.
2004: Phyllis J Goodman; Catherine M Tangen; John J Crowley; Susan M Carlin; Anne Ryan; Charles A Coltman; Leslie G Ford; Ian M Thompson
Implementation of the Prostate Cancer Prevention Trial (PCPT).
Controlled clinical trials 2004;25(2):203-22.
2003: Joseph M Unger; Michael LeBlanc; John J Crowley; H Barton Grossman; Ronald B Natale; Antoinette J Wozniak; James R Berenson; Alan F List; William A Peters; Robert C Flanigan; John S Macdonald; Muhyi Al-Sarraf; Ian M Thompson; Charles A Coltman
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23 Suppl):246s-252s.
2003: Ian M Thompson; Eric A Klein; Scott M Lippman; Charles A Coltman; Bob Djavan
Prevention of prostate cancer with finasteride: US/European perspective.
European urology 2003;44(6):650-5.
2003: Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R. Duane Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
The influence of finasteride on the development of prostate cancer.
The New England journal of medicine 2003;349(3):215-24.
2003: Eric A Klein; Scott M Lippman; Ian M Thompson; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles A Coltman
The selenium and vitamin E cancer prevention trial.
World journal of urology 2003;21(1):21-7.
2003: E David Crawford; David P Wood Jr; Daniel P Petrylak; Jennifer Scott; Charles A Coltman; Derek Raghavan
Southwest Oncology Group studies in bladder cancer.
Cancer 2003;97(8 Suppl):2099-108.
2003: Eric A Klein; Ian M Thompson; Scott M Lippman; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles A Coltman
SELECT: the selenium and vitamin E cancer prevention trial.
Urologic oncology 2003;21(1):59-65.
2001: Eric A Klein; Ian M Thompson; Scott M Lippman; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles A Coltman
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.
The Journal of urology 2001;166(4):1311-5.
2001: Ashraful Hoque; Demetrius Albanes; Scott M Lippman; Margaret R Spitz; Philip R Taylor; Eric A Klein; Ian M Thompson; Phyllis Goodman; J L Stanford; John J Crowley; Charles A Coltman; Regina M Santella
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Cancer causes & control : CCC 2001;12(7):627-33.
2001: Ian M Thompson; M Kouril; Eric A Klein; Charles A Coltman; A Ryan; Phyllis Goodman
The Prostate Cancer Prevention Trial: Current status and lessons learned.
Urology 2001;57(4 Suppl 1):230-4.
2000: Carol M Moinpour; J O Atkinson; S M Thomas; S M Underwood; C Harvey; J Parzuchowski; Laura C Lovato; A M Ryan; M S Hill; Edward P DeAntoni; Ellen R Gritz; Ian M Thompson; Charles A Coltman
Minority recruitment in the prostate cancer prevention trial.
Annals of epidemiology 2000;10(8 Suppl):S85-91.
2000: Carol M Moinpour; Laura C Lovato; Ian M Thompson; John Ware; Patricia Anne Ganz; D L Patrick; Sally A Shumaker; Gary W Donaldson; A Ryan; Charles A Coltman
Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1942-53.
1999: Laura F Hutchins; Joseph M Unger; J J Crowley; Charles A Coltman; Kathy S Albain
Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
The New England journal of medicine 1999;341(27):2061-7.
1999: B R Leigh; David R Gandara; J J Crowley; K Furuse; Robert B Livingston; M Fukushima; Charles A Coltman
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998.
Lung cancer (Amsterdam, Netherlands) 1999;24(3):181-91.
1997: E David Crawford; Edward P DeAntoni; Maha Hussain; Ian M Thompson; Charles A Coltman
Prostate cancer clinical trials of the Southwest Oncology Group.
Oncology (Williston Park, N.Y.) 1997;11(8):1154-63; discussion 1163-70.
1997: Robert B Livingston; R Tsuchiya; M Fukushima; Charles A Coltman
Summary of the proceedings of the United States-Japan lung cancer clinical trials summit. Maui, Hawaii, 24-25 February 1996.
Journal of cancer research and clinical oncology 1997;123(8):461-6.